Vaccine Hesitancy and the COVID-19 Vaccines

Melbourne Region Leadership Team

This event will supported nurses in understanding the efficacy of COVID-19 vaccines, the impact of immunisation on community health and reducing spread of COVID, as well as managing vaccine hesitancy.

Presented by:

• Professor Tony Blakely - Director of the Population Interventions Unit within the Centre for Epidemiology and Biostatistics at the Melbourne School of Population and Global Health • Sonja Elia - Immunisation Nurse Practitioner • Professor Katie Flanagan - Head of Infectious Diseases at Launceston General Hospital, Clinical Professor at the University of Tasmania, Adjunct Professor at RMIT, and Adjunct Associate Professor at Monash University

Vaccine Hesitancy and the COVID-19 Vaccines

Your price: 15.00

Quantity:

Free for Members

Non-Members: $15.00

Content Type: Webinar recording

Duration: 1:25:39

CPD Hours: 1.00

Created: Thursday, 25 March 2021

Area/s of Study

Clinical skills
Immunisation

Related CPD courses


Navigating The Australian Immunisation handbook The Australian Immunisation handbook is an invaluable resource when administering vaccines as per the National Immunisation program and also with catch-up. This CPD module is a tutorial on navigating the online handbook, locating the inform....
Post Operative Nausea and Vomiting Postoperative nausea and vomiting (PONV) is a common occurrence following anesthesia and leads to patient dissatisfaction and?discomfort. In certain settings, PONV?can lead to postoperative complications. This learning module will provide y....
ECG Interpretation Having a good understanding of ECG interpretation is essential to help diagnose and monitor cardiovascular conditions. This module will provide a basic framework for analysing an ECG, including a step-by-step method for evaluating rhythm, r....
Vaccination for People at Occupational Risk Vaccinations for the various occupational groups is essential as some of these workers, for example, healthcare workers and carers, work with vulnerable people, e.g., people =65 years of age, children and people who are immunocompromised. I....